Kodiak Sciences Inc (KOD)
9.295
-0.02
(-0.27%)
USD |
NASDAQ |
Jan 07, 12:33
Kodiak Sciences Research and Development Expense (Quarterly): 31.88M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc | 2.598B |
| Regeneron Pharmaceuticals Inc | 1.272B |
| Revance Therapeutics Inc | 11.38M |
| Editas Medicine Inc | 47.64M |
| Arcutis Biotherapeutics Inc | 19.50M |